Emergent BioSolutions

Emergent BioSolutions' CEO Discusses Q1 2013 Results - Earnings Call Transcript

Emergent BioSolutions' CEO Discusses Q1 2013 Results - Earnings Call Transcript

Seeking Alpha

Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab

Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab

Reuters

Emergent BioSolutions Secures Exclusive U.S. Commercial Rights to Next Generation Pandemic Influenza Vaccine Candidate

Emergent BioSolutions Secures Exclusive U.S. Commercial Rights to Next Generation Pandemic Influenza Vaccine Candidate

Yahoo/BusinessWire

HGSI Will Take Massive Hit If Albiglutide, Darapladib Fail

HGSI Will Take Massive Hit If Albiglutide, Darapladib Fail

Seeking Alpha

Emergent Biosolutions gains on earnings report

Emergent Biosolutions gains on earnings report

Marketwatch

Emergent BioSolutions Earnings Preview

Emergent BioSolutions Earnings Preview

Motley Fool

Sector Snap: Specialty drugs in 2012

Sector Snap: Specialty drugs in 2012

BusinessWeek

Biotech Post-Holiday Regifting

Biotech Post-Holiday Regifting

Motley Fool

Emergent BioSolutions potential leukemia treatment receives 'orphan drug' status from FDA

Emergent BioSolutions potential leukemia treatment receives 'orphan drug' status from FDA

Yahoo/AP